Iron Therapy (Nutrexin USA)
Welcome to the PulseAid listing for the Iron Therapy drug offered from Nutrexin USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nutrexin USA |
NON-PROPRIETARY NAME: | Chininum Arsenicosum, Cuprum Sulphuricum, Ferrum Metallicum, Ferrum Phosphoricum, Zincum Metallicum |
SUBSTANCE NAME: | QUININE ARSENATE; CUPRIC SULFATE; IRON; FERROSOFERRIC PHOSPHATE; ZINC |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2015-02-23 |
END MARKETING DATE: | 0000-00-00 |
Iron Therapy HUMAN OTC DRUG Details:
Item Description | Iron Therapy from Nutrexin USA |
LABELER NAME: | Nutrexin USA |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12; 6; 8; 8; 12([hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1; [hp_X]/1) |
START MARKETING DATE: | 2015-02-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69173-0001_8059c5e6-0d01-46d0-a2ed-2eea7509b36f |
PRODUCT NDC: | 69173-0001 |
APPLICATION NUMBER: | |
Other QUININE ARSENATE; CUPRIC SULFATE; IRON; FERROSOFERRIC PHOSPHATE; ZINC Pharmaceutical Manufacturers / Labelers: